Icogenex Bioincubator
Share
With access to specialized equipment, flexible lease terms, and the ability to grow or contract as needed in a fully managed facility, you can focus on your business without unexpected hassles or expense.
04/24/2023
Icogenex Bioincubator is excited to be attending LSINW 2023 and presenting in the Entrepreneurial Forum on Wednesday. Hope to see you there.
12/06/2016
Oculus is now Sonoma Pharmaceuticals!
Oculus Innovative Sciences Announces Corporate Name Change to Sonoma Pharmaceuticals, Inc. and New NASDAQ Ticker Symbol to Better Align with Dermatology Focus
PETALUMA, CA — (December 5, 2016) —Oculus Innovative Sciences, Inc. (NASDAQ: OCLS, warrants OCLSW), a specialty pharmaceutical company that develops and markets solutions for the treatment of dermatological conditions and advanced tissue care, today announced that on December 6, 2016, it will officially change the name of the company to Sonoma Pharmaceuticals, Inc. In conjunction with the name change, the company’s ticker symbol listed on the NASDAQ will change from OCLS to SNOA (warrants SNOAW), effective December 6, 2016. The company’s new web site will be www.sonomapharma.com.
“We are pleased to align our corporate name and identity with our strategic initiative as a specialty pharmaceutical company focused on the high-margin U.S. dermatology market,” said Jim Schutz, CEO of Sonoma Pharmaceuticals. "
The Seattle crew form Sonoma Pharmaceuticals at Icogenex Bioincubator
06/15/2016
Congratulations to Alpine Immune Sciences, a current tenant at Icogenex Bioincubator.
Alpine pulls in $48 million; tops for a local biotech this year Alpine Immune Sciences will use the funds to create therapies that treat both cancer and autoimmune disorders.
Click here to claim your Sponsored Listing.
Category
Telephone
Address
454 N 34th Street
Seattle, WA
98103
